Exposure–response Analysis and Simulation of Lenvatinib Safety and Efficacy in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-018-3687-4
Full Text
Open PDFAbstract
Available in full text
Date
September 22, 2018
Authors
Publisher
Springer Science and Business Media LLC